Human proteomics: From the operating room to the lab and back
Human proteomics: From the operating room to the lab and back
Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarker identification using proteomic tools. A series of studies using human eye fluids has helped to diagnose inflammatory retinal disease, select personalized therapies, stage cancer, and point to new therapeutic strategies. These approaches can be broadly applied to human surgical disease.
Learning Objectives
- Learn workflow for human surgical specimen collection
- Learn human disease proteomics experimental design
- Learn future applications of human proteomics to disease diagnosis and treatment
Vinit Mahajan, MD, PhD
Vice Chair for Research, Director, Omics Lab, Molecular Surgery Program
Stanford University
Dr. Mahajan is a vitreoretinal surgeon and professor in the Department of Ophthalmology at Stanford University. He is the Vice Chair for Research and directs the Molecular Surgery Program and the NIH-funded Omics Laboratory that uses high-throughput methods in proteomics, genomics, and phenomics to identify molecules involved in eye disease. His research team discovered the first gene to cause non-syndromic uveitis and is now using protein crystallography to design therapeutic inhibitors for calpain-5. Mahajan and his team performed the first CRISPR gene editing therapy for eye disease in human stem cells. Using translational proteomics, Mahajan’s multidisciplinary team is developing new precision health approaches using molecular biomarkers to diagnose retinal disease, select personalized therapies, and decode the anatomic structures of the human eye.
Human proteomics: from the operating room to the lab and back
A presentation by Vinit Mahajan, MD, PhD
More webinars
WebinarFinding the signal: Identifying reproducible biomarkers in high-plex proteomics
In biomarker discovery, the challenge is rarely a lack of data. Rather, it is knowing how to separate meaningful biological signal from technical distraction. This webinar focuses on how to use univariate analysis as a practical and powerful entry point for biomarker discovery in high-plex proteomics studies.
WebinarMore than the sum of its parts: How harmonized proteomic data reveals meaning across disparate clinical cohorts
Proteomics data generated across sites, time points, and workflows can be difficult to compare using standard normalization alone. This webinar shows how harmonization aligns datasets into a shared biological framework and reveals signals across studies and cohorts, highlighted through the GNPC’s analysis of 40,000 patient samples.
WebinarPathways to Digital Health: AI and Omics in Rheumatoid Arthritis
Explore how groundbreaking proteomic research is transforming our understanding of rheumatoid arthritis (RA). In this on-demand webinar, Allan Stensballe, PhD, shares new insights into the molecular landscape of RA-affected synovial tissue, revealing how autoantibodies and protein signatures may hold the key to more precise personalized therapies.